Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Medtronic PLC (MDT) trades at a P/S ratio of 3.2×. Over the past ten years it has ranged from 2.6× (June 2026) to 6.3× (April 2021); the current reading is higher than 9% of that period. That is above the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 2.9× (12.16%)
FY2025 3.2× (1.29%)
FY2024 3.3× (14.76%)
FY2023 3.9× (11.63%)
FY2022 4.4× (25.26%)
FY2021 5.8× 29.14%
FY2020 4.5× 15.69%
FY2019 3.9× 7.82%
FY2018 3.6× (6.62%)
FY2017 3.9× 0.19%

Quarterly newest first

Period P/S ratio Change
Jul 2026 2.9× 1.99%
Apr 2026 2.9× (23.12%)
Jan 2026 3.7× 10.98%
Oct 2025 3.3× (1.07%)
43 more quarters

Against its own ten years

Low 2.6× High 6.3×
Ten-year median 3.9×
Current reading's percentile 9

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MDT